Published in Cancer Med on April 16, 2014
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell (2008) 11.18
Imaging in the era of molecular oncology. Nature (2008) 11.10
Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol (2005) 9.57
ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science (2008) 5.54
Targeting mitochondria for cancer therapy. Nat Rev Drug Discov (2010) 4.07
Molecular imaging in drug development. Nat Rev Drug Discov (2008) 4.06
Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science (2009) 3.89
A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun (1993) 3.79
JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett (1997) 3.41
Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res (2005) 3.26
Mitochondria in cancer cells: what is so special about them? Trends Cell Biol (2008) 2.97
Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem (1985) 2.18
The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle (2008) 2.09
Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci U S A (2007) 2.01
Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta (2011) 2.00
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Mol Aspects Med (2010) 1.84
Mitochondrial dysfunction in cancer. Mitochondrion (2004) 1.77
Impact of albumin on drug delivery--new applications on the horizon. J Control Release (2011) 1.72
Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc Natl Acad Sci U S A (1982) 1.72
Mitochondria-targeted small molecule therapeutics and probes. Antioxid Redox Signal (2011) 1.66
Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol (2009) 1.61
Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol (2007) 1.45
Basis for the selective cytotoxicity of rhodamine 123. Cancer Res (1987) 1.32
Mitochondrial gateways to cancer. Mol Aspects Med (2009) 1.28
Targeting mitochondria with organelle-specific compounds: strategies and applications. Chembiochem (2009) 1.26
Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. Front Biosci (Landmark Ed) (2009) 1.16
Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol (2008) 1.14
Ratiometric analysis of fluorescence lifetime for probing binding sites in albumin with near-infrared fluorescent molecular probes. Photochem Photobiol (2007) 1.14
Drug delivery to tumours: recent strategies. J Pharm Pharmacol (2005) 1.13
Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green. Int J Cancer (2011) 1.12
A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials (2010) 1.09
Mitochondrially targeted anti-cancer agents. Mitochondrion (2010) 1.08
Clinical impact of serum proteins on drug delivery. J Control Release (2011) 1.07
Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation. Eur J Nucl Med Mol Imaging (2007) 1.02
Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate (2009) 1.01
Targeting mitochondria as a therapeutic target in cancer. J Cell Physiol (2012) 1.01
Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med (1998) 0.99
Mitochondrial viability in mouse and human postmortem brain. FASEB J (2010) 0.92
Preferential accumulation of (3)H-tetraphenylphosphonium in non-small cell lung carcinoma in mice: comparison with (99m)Tc-MIBI. J Nucl Med (2002) 0.88
64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging. Bioconjug Chem (2011) 0.87
The solvatochromic effects of side chain substitution on the binding interaction of novel tricarbocyanine dyes with human serum albumin. Talanta (2012) 0.82
Fluorescence spectroscopic investigation of competitive interactions between ochratoxin A and 13 drug molecules for binding to human serum albumin. Luminescence (2012) 0.82
Myocardial 99mTc-sestamibi extraction and washout in hypertensive heart failure using an isolated rat heart. Nucl Med Biol (2010) 0.79
Spectroscopic investigation on the interaction of J-aggregate with human serum albumin. Biophys Chem (2007) 0.79
Mitochondria and membrane cryoinjury in micropatterned cells: effects of cell-cell interactions. Cryobiology (2010) 0.78
Development of novel nanocarrier-based near-infrared optical probes for in vivo tumor imaging. J Fluoresc (2011) 0.78
A strategy for increasing the brain uptake of a radioligand in animals: use of a drug that inhibits plasma protein binding. Nucl Med Biol (2000) 0.77
Regulatory T cells and immune tolerance. Cell (2008) 18.77
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev (2006) 10.24
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity (2009) 9.01
(18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med (2004) 2.32
Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg (2013) 2.29
Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg (2011) 2.07
Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity (2009) 2.05
Follicular helper T cell signature in type 1 diabetes. J Clin Invest (2014) 1.61
Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens. J Gastroenterol (2003) 1.54
HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog (2011) 1.53
Pre-cutting using a noseless papillotome with independent lumens for contrast material and guidewire. J Gastroenterol Hepatol (2005) 1.53
Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo. J Control Release (2012) 1.50
Is a computerized bowel sound auscultation system useful for the detection of increased bowel motility? Am J Gastroenterol (2002) 1.41
Quantification in SPECT cardiac imaging. J Nucl Med (2003) 1.41
Skeletal affinity of Tc(V)-DMS is bone cell mediated and pH dependent. Eur J Nucl Med Mol Imaging (2003) 1.40
Is MIBG a substrate of P-glycoprotein? Eur J Nucl Med Mol Imaging (2006) 1.37
Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors. Nucl Med Biol (2006) 1.22
Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study. J Nucl Med (2007) 1.17
Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med (2006) 1.13
Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability--analysis in hypercholesterolemic rabbits. Atherosclerosis (2007) 1.13
Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotron. Nucl Med Biol (2003) 1.11
GLP-1 receptor antagonist as a potential probe for pancreatic beta-cell imaging. Biochem Biophys Res Commun (2009) 1.10
Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J Nucl Med (2008) 1.02
Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection. J Gastroenterol Hepatol (2003) 0.98
Quantitative analysis of pharmaceutical drug distribution in multiple organs by imaging mass spectrometry. Rapid Commun Mass Spectrom (2012) 0.98
Thoracoscopic ethanol injection and radiofrequency ablation for the treatment of hepatocellular carcinoma located immediately under the diaphragm. Int J Oncol (2006) 0.97
Continuous cerebrovascular reactivity monitoring and autoregulation monitoring identify similar lower limits of autoregulation in patients undergoing cardiopulmonary bypass. Neurol Res (2013) 0.96
Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation. Eur J Immunol (2011) 0.96
Development of injectable O-15 oxygen and estimation of rat OEF. J Cereb Blood Flow Metab (2003) 0.96
Applicability of a high-resolution small semiconductor gamma camera to small animal imaging. Nucl Med Commun (2007) 0.95
Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals. Bioconjug Chem (2005) 0.94
BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques. ACS Chem Neurosci (2012) 0.93
Fluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of beta-amyloid plaques in Alzheimer's disease. J Med Chem (2009) 0.93
Radiolabelled probes for imaging of atherosclerotic plaques. Am J Nucl Med Mol Imaging (2012) 0.93
Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT. J Nucl Med (2004) 0.93
Radioiodinated benzimidazole derivatives as single photon emission computed tomography probes for imaging of β-amyloid plaques in Alzheimer's disease. Nucl Med Biol (2010) 0.92
Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent. J Nucl Med (2006) 0.91
Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques. Eur J Nucl Med Mol Imaging (2010) 0.90
Push-pull benzothiazole derivatives as probes for detecting beta-amyloid plaques in Alzheimer's brains. Bioorg Med Chem (2009) 0.90
Protective effect of zinc against ischemic neuronal injury in a middle cerebral artery occlusion model. J Pharmacol Sci (2006) 0.90
Direct electrophilic radiofluorination of a cyclic RGD peptide for in vivo alpha(v)beta3 integrin related tumor imaging. Nucl Med Biol (2003) 0.90
Basic characterization of 64Cu-ATSM as a radiotherapy agent. Nucl Med Biol (2005) 0.90
99mTc-Annexin A5 for noninvasive characterization of atherosclerotic lesions: imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits. Eur J Nucl Med Mol Imaging (2007) 0.90
Novel radioiodinated aurones as probes for SPECT imaging of beta-amyloid plaques in the brain. Bioconjug Chem (2009) 0.90
Selenium binding to human hemoglobin via selenotrisulfide. Biochim Biophys Acta (2005) 0.90
Tissue factor detection for selectively discriminating unstable plaques in an atherosclerotic rabbit model. J Nucl Med (2010) 0.90
Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors. Eur J Nucl Med Mol Imaging (2007) 0.89
Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains. J Med Chem (2011) 0.89
Tissue-derived hedgehog proteins modulate Th differentiation and disease. J Immunol (2013) 0.89
Molecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration. Gastroenterol Res Pract (2012) 0.89
Synthesis and evaluation of fluorine-substituted 1H-pyrrolo[2,3-b]pyridine derivatives for dopamine D4 receptor imaging. Bioorg Med Chem (2004) 0.89
Distribution profiles of membrane Type-1 matrix metalloproteinase (MT1-MMP), matrix metalloproteinase-2 (MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis: comparison with plaque instability analysis. Biol Pharm Bull (2007) 0.89
Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice. J Pharm Sci (2014) 0.89
Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biol Pharm Bull (2008) 0.88
Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer's brains. ACS Chem Neurosci (2011) 0.88
Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol (2014) 0.87
A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells. J Control Release (2010) 0.86
Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors. Biol Pharm Bull (2009) 0.86
18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains. Bioorg Med Chem (2009) 0.86
Synthesis and evaluation of radioiodinated (S,S)-2-(alpha-(2-iodophenoxy)benzyl)morpholine for imaging brain norepinephrine transporter. Eur J Nucl Med Mol Imaging (2006) 0.86
Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma. Int J Oncol (2006) 0.86
Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole. J Gastroenterol Hepatol (2003) 0.86
Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG. Nucl Med Biol (2003) 0.85
Estimation of oxygen metabolism in a rat model of permanent ischemia using positron emission tomography with injectable15O-O2. J Cereb Blood Flow Metab (2006) 0.85
Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection. J Gastroenterol (2002) 0.85
Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains. J Med Chem (2006) 0.85
Synthesis and evaluation of novel chalcone derivatives with (99m)Tc/Re complexes as potential probes for detection of β-amyloid plaques. ACS Chem Neurosci (2010) 0.85
Development and evaluation of a novel (99m)tc-labeled annexin A5 for early detection of response to chemotherapy. PLoS One (2013) 0.84
Development of dual functional SPECT/fluorescent probes for imaging cerebral beta-amyloid plaques. Bioorg Med Chem Lett (2010) 0.84
A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of β-amyloid plaques in the brain. Bioorg Med Chem Lett (2011) 0.84
Synthesis and evaluation of radioiodinated cyclooxygenase-2 inhibitors as potential SPECT tracers for cyclooxygenase-2 expression. Nucl Med Biol (2006) 0.84
SPECT Imaging Agents for Detecting Cerebral β-Amyloid Plaques. Int J Mol Imaging (2011) 0.84
Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors. Nucl Med Biol (2007) 0.84
PET O-15 cerebral blood flow and metabolism after acute stroke in spontaneously hypertensive rats. Brain Res (2008) 0.83
Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection. Cancer Sci (2011) 0.83
Rhemium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliation. Nucl Med Biol (2006) 0.83
Release of vesicular Zn2+ in a rat transient middle cerebral artery occlusion model. Brain Res Bull (2006) 0.83
Skin disease modeling from a mathematical perspective. J Invest Dermatol (2013) 0.83
5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects. Ann Nucl Med (2004) 0.82
Radioiodinated peptide probe for selective detection of oxidized low density lipoprotein in atherosclerotic plaques. Nucl Med Biol (2012) 0.82
Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits. J Am Chem Soc (2014) 0.82
Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1alpha. Eur J Nucl Med Mol Imaging (2010) 0.82
Sensory stimulation accelerates dopamine release in the basal ganglia. Brain Res (2004) 0.82